Supplementary Data from Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma

Xue Cheng,Xiaosheng Tan,Wei Wang,Ziyao Zhang,Rongfei Zhu,Mi Wu,Mingyu Li,Yiqing Chen,Zhihui Liang,Peng Zhu,Xiongwen Wu,Xiufang Weng

DOI: https://doi.org/10.1158/0008-5472.22433526.v1

2023-01-01

Abstract:supplementary figures and figure legends

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Wenqun Zhong,Zhang Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23952936.v1

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Long-chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma.

Xue Cheng,Xiaosheng Tan,Wei Wang,Ziyao Zhang,Rongfei Zhu,Mi Wu,Mingyu Li,Yiqing Chen,Zhihui Liang,Peng Zhu,Xiongwen Wu,Xiufang Weng

DOI: https://doi.org/10.1158/0008-5472.can-22-2273

IF: 11.2

2022-01-01

Cancer Research

Abstract:AbstractCD1d-restricted invariant natural killer T (iNKT) cells actively patrol the liver and possess valuable antitumor potential. However, clinical trials evaluating administration of iNKT cell–specific agonist α-galactosylceramide (α-GalCer) have failed to achieve obvious tumor regression. Improving the efficacy of iNKT cell–based immunotherapy requires a better understanding of the factors restraining the clinical benefits. In the context of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we found circulating and hepatic iNKT cells were hyperactivated but demonstrated imbalances in ratio and defective α-GalCer responsiveness. Exogenous IL2 helped to expand residual α-GalCer–responsive clones with reduced T-cell receptor diversity. However, transcriptome-wide analysis revealed activation of the senescence-associated secretory phenotype and dampened cytotoxicity in iNKT cells, weakening their immune surveillance capacity. The senescent status of iNKT cells from the patients was further illustrated by cell-cycle arrest, impaired telomere maintenance, perturbed calcium transport-related biological processes, and altered metabolism. Lipidomic profiling revealed the accumulation of long-chain acylcarnitines (LCAC) and aberrant lipid metabolism in HCC tissue. Exogenous LCACs, especially palmitoyl-carnitine and stearoyl-carnitine, inhibited iNKT cell expansion and promoted senescence. Collectively, our results provide deeper insights into iNKT cell dysregulation and identify a cell senescence–associated challenge for iNKT cell–based immunotherapy in HBV-related HCC. The mechanistic links between iNKT cell senescence and accumulated LCACs suggest new targets for anti-HCC immunotherapies.Significance:Patients with HBV-related HCC exhibit a cell senescence–associated dysregulation of invariant natural killer cells that is related to altered lipid metabolism and accumulated LCACs in tumor tissue.
Supplementary Data from β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma

Ye Wang,Chunxiao Cheng,Yanjun Lu,Zhaowu Lian,Qi Liu,Yanchao Xu,Yunzheng Li,Huan Li,Laizhu Zhang,Xiang Jiang,Binghua Li,Decai Yu

DOI: https://doi.org/10.1158/0008-5472.25826447

2024-01-01

Abstract:<p>Supplementary Figures: S1-S16; Supplementary Methods; Supplementary Materials; Supplementary Cell lines authentication</p>
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
Supplementary Data from Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy

Ming Mu,Chun-Xiang Huang,Chenxu Qu,P. Li,X. Wu,Wudexin Yao,Chu Shen,Ruxun Huang,Chao-Chao Wan,Zhi-Wei Jian,Limin Zheng,Ruiqi Wu,Xiang‐Ming Lao,Dong‐Ming Kuang

DOI: https://doi.org/10.1158/0008-5472.25415352

2024-01-01

Abstract:Supplementary Figures and Tables
Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Dong‐Tsamn Lin,Lei,Yonghao Liu,Yinsheng Zhang,Bo Hu,Guirong Bao,Songliu Yuan,Jin Zou,Chunliang Liu,Miao Yu,Dedy Sandikin,Yan Wu,Lei Zhao,Yu X,Haiyan Liu

DOI: https://doi.org/10.1158/0008-5472.22408238

2023-01-01

Abstract:Supplemental figure legends
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Data from Epigenetic Induction of Mitochondrial Fission is Required for Maintenance of Liver Cancer–Initiating Cells

Miaoling Tang,Meisongzhu Yang,Geyan Wu,Shuang Mo,Xingui Wu,Shuxia Zhang,Ruyuan Yu,Yameng Hu,Yingru Xu,Ziwen Li,Xinyi Liao,Jun Li,Libing Song

DOI: https://doi.org/10.1158/0008-5472.22428529.v1

2023-01-01

Abstract:This document contains Supplemental Materials and Methods and Supplementary Data
Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Ye Tian,Vincent W. S. Wong,Grace L.H. Wong,Weiqin Yang,Hanyong Sun,Jiayun Shen,Joanna H.M. Tong,Minnie Y.Y. Go,Yu-San Cheung,Paul B.S. Lai,Mi Zhou,Gang Xu,Tim H.‐M. Huang,Yuanyuan Wang,Ka Fai To,Alfred S.L. Cheng,Henry Lik‐Yuen Chan

DOI: https://doi.org/10.1158/0008-5472.22412076

2023-01-01

Abstract:HDAC8 promotes growth and inhibits apoptosis of HCC cells.
Supplementary Data from NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres During Mitosis

Zhao Zhen,Helge Gad,Carlos Benitéz‐Buelga,Kumar Sanjiv,Xing Hua,Kaitlyn He,Feng Mao,Zhiyao Zhao,Ulrika Warpman Berglund,Qiang Xia,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22429195.v1

2023-01-01

Abstract:Supplementary Data from NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis
Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Jialei Weng,Zheng Wang,Zhiqiu Hu,Wenxin Xu,Jia-Lei Sun,Fu Wang,Qiang Zhou,Shaoqing Liu,Min Xu,Minghao Xu,Dongmei Gao,Ying-Hao Shen,Yong Yi,Yi Shi,Qiongzhu Dong,Chenhao Zhou,Ning Ren

DOI: https://doi.org/10.1158/0008-5472.25964573.v1

2024-01-01

Abstract:The Supplementary Data consist of: Supplementary Tables S1-7
Supplementary Methods, Figure Legends from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Shinan Li,Rui Sun,Yongyan Chen,Wei H,Zhigang Tian

DOI: https://doi.org/10.1158/0008-5472.22407825

2023-01-01

Abstract:Supplemental Materials and Methods and Figure Legends
Supplementary Data from Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma

Cho-Hao Lin,Khadija H. Elkholy,Nissar Ahmad Wani,Li Ding,Ping Hu,Juan M. Barajas,Lianbo Yu,Xiaoli Zhang,Samson T. Jacob,Wasif N. Khan,Xuefeng Bai,Anne M. Noonan,Kalpana Ghoshal

DOI: https://doi.org/10.1158/1535-7163.22506318

2023-01-01

Abstract:Supplementary figures and tables
Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

Zhen–Bin Ding,Bo Hui,Ying‐Hong Shi,Jing Zhou,Yuan‐Fei Peng,Chengyu Gu,Hua Ye,Guo‐Ming Shi,Ai‐Wu Ke,Xiaoying Wang,Kun Song,Zhi Dai,Yongchun Shen,Jia Fan

DOI: https://doi.org/10.1158/1078-0432.22443171.v1

2023-01-01

Abstract:PDF file - 594K, Analysis of transfection efficiency by fluorescent microscopy.
Supplementary Figure 7 from Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis

Yi Zhang,Yan Cheng,Xingcong Ren,Tsukasa Hori,Kathryn J. Huber-Keener,Li Zhang,Kai Lee Yap,David Liu,Lisa Shantz,Zheng-Hong Qin,Suping Zhang,Jianrong Wang,Hong-Gang Wang,Ie-Ming Shih,Jin-Ming Yang

DOI: https://doi.org/10.1158/0008-5472.22392797

2023-01-01

Abstract:PDF file - 76K, Effect of NAC1 status on proliferation of immortalized MEFs transduced with Ras
Supplementary Data from the Hepatic Microenvironment Uniquely Protects Leukemia Cells Through Induction of Growth and Survival Pathways Mediated by LIPG

Haobin Ye,Mohammad Minhajuddin,Anna Krug,Shanshan Pei,Chih-Hsing Chou,Rachel Culp‐Hill,Jessica Ponder,Erik De Bloois,Björn Schniedewind,M.F. Amaya,Anagha Inguva,Brett M. Stevens,Daniel A. Pollyea,Uwe Christians,H. Leighton Grimes,Angelo D’Alessandro,Craig T. Jordan

DOI: https://doi.org/10.1158/2159-8290.22536566

2023-01-01

Abstract:Supplementary figures and information
Supplementary Data from Proapoptotic Function of Integrin Β3 in Human Hepatocellular Carcinoma Cells

Yanhua Wu,Jie Zuo,Guoqing Ji,Hexige Saiyin,Xing Liu,Feiyu Yin,Ning Cao,Yunfei Wen,Jian,Long Yu

DOI: https://doi.org/10.1158/1078-0432.22439821

2023-01-01

Abstract:Supplementary Data from Proapoptotic Function of Integrin β3 in Human Hepatocellular Carcinoma Cells
Supplementary Figure Legends 1-4 from The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Zhongguang Luo,Guangyang Yu,Hyuk Woo Lee,Lihui Li,Lingyan Wang,Dongqin Yang,Yongfu Pan,Chan Ding,Jing Qian,Lijun Wu,Yiwei Chu,Jing Yi,Xiangdong Wang,Yi Sun,Lak Shin Jeong,Jie Liu,Lijun Jia

DOI: https://doi.org/10.1158/0008-5472.22393787

2023-01-01

Abstract:<p>PDF file - 94K</p>
Supplementary Figure S1 from Immune Checkpoint Inhibition is Safe and Effective for Liver Cancer Prevention in a Mouse Model of Hepatocellular Carcinoma

Angie Y. Chung,Marcel Mettlen,Debolina Ganguly,Tianshi Lü,Tao Wang,Rolf A. Brekken,David Hsiehchen,Hai‐Liang Zhu

DOI: https://doi.org/10.1158/1940-6207.22534835.v1

2023-01-01

Abstract:Neoantigens tend to increase with worsening fibrosis stage.

Supplementary Data from Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Long-chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma.

Supplementary Data from β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Data from Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy

Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Data from Epigenetic Induction of Mitochondrial Fission is Required for Maintenance of Liver Cancer–Initiating Cells

Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Supplementary Data from NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres During Mitosis

Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Methods, Figure Legends from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Supplementary Data from Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma

Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

Supplementary Figure 7 from Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis

Supplementary Data from the Hepatic Microenvironment Uniquely Protects Leukemia Cells Through Induction of Growth and Survival Pathways Mediated by LIPG

Supplementary Data from Proapoptotic Function of Integrin Β3 in Human Hepatocellular Carcinoma Cells

Supplementary Figure Legends 1-4 from The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Supplementary Figure S1 from Immune Checkpoint Inhibition is Safe and Effective for Liver Cancer Prevention in a Mouse Model of Hepatocellular Carcinoma